Alternate Health Club vs Corsica Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alternate Health Club
Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platformStarting at $129/mo
Corsica Health
Best for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparisonStarting at $299/mo
Side-by-Side Comparison
| Feature | Alternate Health Club | Corsica Health |
|---|---|---|
| Overall Score | 7.3/10 | ✓7.5/10 |
| Starting Price | ✓$129/mo | $299/mo |
| Editorial Rating | 3.7 ★ /5 | ✓3.8 ★ /5 |
| Features | 6 features | ✓9 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alternate Health Club
Pros
- ✓$129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- ✓$169/month compounded tirzepatide is competitive with established compounded-tirz platforms
- ✓Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
- ✓LegitScript Verified seal displayed in the footer
- ✓U.S.-licensed clinicians explicitly mentioned
Cons
- ✗Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- ✗State of incorporation NOT disclosed
- ✗Per-state availability NOT enumerated — verify your state ships before committing
- ✗Pharmacy partners NOT publicly named — material YMYL transparency gap
- ✗Lab work NOT clearly disclosed as included
- ✗Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
- ✗First-month discount or trial offer NOT disclosed
Corsica Health
Pros
- ✓Public pricing disclosure for BOTH compounded and brand-name SKUs on marketing site — material YMYL transparency advantage vs peers
- ✓$299/month compounded semaglutide and $399/month compounded tirzepatide are in the median range for compounded telehealth
- ✓$1,499/month brand-name Wegovy/Ozempic/Mounjaro pricing is below typical retail cash-pay (~$1,300-$1,800)
- ✓LegitScript-approved seal displayed with verification link
- ✓Structured 3-step intake (Assessment → Provider Review → Receive Medication) clearly disclosed
Cons
- ✗Specific legal entity name + state of incorporation NOT publicly disclosed on the home page
- ✗Pharmacy partners described as 'licensed compounding pharmacy' but specific name NOT disclosed
- ✗Per-state availability NOT enumerated publicly
- ✗Zepbound and Foundayo NOT mentioned in the brand-name lineup (only Wegovy/Ozempic/Mounjaro)
- ✗First-month promotional pricing NOT disclosed (assumed steady-state from day one)
- ✗Lab work inclusion NOT clearly disclosed in marketing copy
Our Verdict
Corsica Health edges out Alternate Health Club with a higher overall score of 7.5/10 and is particularly strong for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparison. Alternate Health Club remains a solid alternative, especially if you're looking for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.